Monday, 15 June 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 15 June 2026
News

Ethics of pharma profits debated

 Posted 15 June 2026 PM

Not subsidising GLP-1 medicines for weight loss increases inequity for disadvantaged groups, an Australian ethics symposium was told. 

“We can get GLP-1s for obesity with heart disease or diabetes with subsidisation on the PBS,” said Professor Ian Kerridge, Professor of Bioethics and Medicine at the University of Sydney, co-hosting the Australian Ethical Health Alliance (AEHA) 2026 Symposium. “But if you want it for just weight loss ... then you pay for it yourself.

To see the whole article, please login

Popular

PBS drug bows out after 35 years
Pharma boss breaks Aussie house record
Pharma drops $39M on meetings
Global high-flyer moving to Aust
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (22)

Access & Reimbursement (1)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (3)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home